XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
0.9652
-0.0147 (-1.50%)
Oct 23, 2025, 12:30 PM EDT - Market open
XWELL Market Cap
XWELL has a market cap or net worth of $5.56 million as of October 23, 2025. Its market cap has decreased by -38.54% in one year.
Market Cap
5.56M
Enterprise Value
7.48M
1-Year Change
-38.54%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since July 20, 2012, XWELL's market cap has decreased from $50.81M to $5.56M, a decrease of -89.06%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 5.64M | -28.92% |
| Dec 31, 2024 | 7.94M | 9.13% |
| Dec 29, 2023 | 7.27M | -75.92% |
| Dec 30, 2022 | 30.20M | -85.80% |
| Dec 31, 2021 | 212.76M | 90.15% |
| Dec 31, 2020 | 111.89M | 994.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 225.41B |